APIs & VITAMINS market

At present, China APIs market remains weak, with the majority of wait-and-see. In terms of supply, although the production load of the factory is declining and the production cost is relatively high, the overall market supply is sufficient. In terms of demand, the market for mid-and downstream breeding enterprises is sluggish after the Chinese New Year holiday. On the whole, most mid-and upstream manufacturers have a certain degree of inventory pressure, and it’s widespread to deliver at reduced prices. The probability of continuous price decline in the market outlook is high, and difficult to predict the bottom accurately.

Terminal demand maintains weak, market inventory pressure increases, the overall price continues to fall, bargaining transaction is common.

The price maintained a weak adjustment, the downward adjustment rate slowed down, and the price was negotiated.

The adjustment trend has been maintained since the beginning of 2022. After continuous adjustment, the current prices of tylosin, tilmicosin and other products are very close to the early bottom. For other veterinary APIs market information and solid inquiries, please feel free to contact us.

The domestic vitamin market generally maintained a stable and weak situation. Most varieties are competing between upstream high price and sluggish downstream demand. While preparing the newsletter, ZMC stopped the quotation of Vitamin E. Calcium pantothenate, and vitamin K3 (MSB) remained in the spotlight.

European VA (1 million IU) tend to gradually provide regular supply since January 2022. Quotation in European market lowered. The price of Vitamin A produced in China is also adjusted downward.

With the gradual consumption of inventory, market inquiries recently increased, quotation rose slightly. ZMC stopped the quotation on Feb. 25th

The dual-control policy on energy consumption has driven the market price of calcium pantothenate to soar in the past six months. Our company believes that there is a high possibility of capital manipulation. We have been paying close attention to the trend of this product. For further details, please get in touch with us.

Affected by the shortage of raw materials and the rising cost, manufacturers are strongly willing to raise prices, and the market is strong.

TYLVADIS:TYLVALOSIN (50mg，250mg, 500mg/g as Tylvalosin Tartrate) for treatment and prevention of respiratory diseases, enteric and other diseases, mainly caused by microorganisms in pigs and chicken.
For more information on this product. C

FLORDIS: Broad Spectrum Antibiotic Against Bacterial Infections. Florfenicol 4% microencapsulated, 10% water-soluble, 20% water-soluble, 20% coated for the treatment of bacterial diseases of pigs, chickens and fish caused by sensitive bacteria, especially for respiratory system infections and intestinal.